Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NetTargets Logo
NetTargets Growth Score
36
CB Rank
127552
Heat Score
56
NetTargets provides AI-focused drug discovery research services.
Founded
obfuscation
PrivateSeries A Yusong, Taejon-jikhalsi, South Korea11-50 www.net-targets.com/
Artificial Intelligence (AI)
Biotechnology
Health Care
Overview

NetTargets
Total Funding
obfuscation
Growth Score
36
Heat Score
56

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score36
-1 pts
in past quarter
Heat Score 56
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NetTargets

CB Rank
127552
NetTargets provides AI-focused drug discovery research services.
Founded
obfuscation
PrivateSeries A Yusong, Taejon-jikhalsi, South Korea11-50 www.net-targets.com/
Artificial Intelligence (AI)
Biotechnology
Health Care

Funding Rounds

Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name NetTargets Inc
Operating Status Active
Company Type For Profit
Founders  Je-Hoon Song, Jongho Baek
Contact Email info@net-targets.com
Predictions & Insights

Products & Services

AI-enhanced Systems Biology Research Platform
A computational platform that integrates chemical, biological, experimental, and clinical data to model biological networks for drug target discovery.
Drug Repurposing Service
A service that uses AI-enhanced systems biology to identify new therapeutic uses for existing drugs by analyzing drug-disease interaction networks.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A
obfuscation
Series A - NetTargets Logo
Series A - NetTargets
6
obfuscation
— Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
DA Value Investment Logo
DA Value Investment
—
Series A - NetTargets Logo
Series A - NetTargets
—
DA Value Investment Logo
DA Value Investment
—
Series A - NetTargets Logo
Series A - NetTargets
—
DA Value Investment Logo
DA Value Investment
—
Series A - NetTargets Logo
Series A - NetTargets
—
DA Value Investment Logo
DA Value Investment
—
Series A - NetTargets Logo
Series A - NetTargets
—
DA Value Investment Logo
DA Value Investment
—
Series A - NetTargets Logo
Series A - NetTargets
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 1

Employee Profiles

News

News and Press

News•Oct 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

59
-34.44%
 in past month

Active Website Tech Count

3NetTargets is actively using 3 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Euro, and  CommonCrawl Top 10m.

Total IP

2The intellectual property of NetTargets includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NetTargets's headquarters? NetTargets is located in Yusong, Taejon-jikhalsi, South Korea.Who invested in NetTargets? NetTargets has 8 investors including DA Value Investment and  Friend Investment Partners.When was the last funding round for NetTargets? NetTargets closed its last funding round on
obfuscation
from a Series A round.Who are NetTargets's competitors? Alternatives and possible competitors to NetTargets may include Insilico Medicine, Nimbus Therapeutics, and  Iktos.How much funding has NetTargets raised to date? NetTargets has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(1fd810a 1)
|